Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Evaluation of Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy

NCT00996437 is registered in ClinicalTrials.gov with Jaeb Center for Health Research as lead sponsor.

NCT NCT00996437
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00996437 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Evaluation of Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy
Lead sponsor
Jaeb Center for Health Research
Phase
Phase 2/3
Overall status
Completed
Start date
June 30, 2010
Completion date
January 31, 2013
Enrollment
261 (actual)
Sites
67

Conditions

As the registry lists them; a condition with its own page is linked.

proliferative diabetic retinopathy, vitreous hemorrhage